Yes, a virus can cause left bundle branch block (LBBB). The primary way this happens is through viral myocarditis, an infection-driven inflammation of the heart muscle that can damage the specialized fibers responsible for conducting electrical signals through the heart. Among over one million COVID-19 hospitalizations tracked in a U.S. national database in 2020, 1.6% of patients developed a new bundle branch block during their stay.
How a Virus Damages the Heart’s Wiring
Your heart relies on a network of specialized fibers to carry electrical impulses from the upper chambers down into the lower chambers in a precisely timed sequence. The left bundle branch is one of two main pathways that deliver those signals to the left ventricle, the heart’s primary pumping chamber. When a virus reaches heart tissue, it can disrupt this pathway through several overlapping mechanisms.
First, the virus invades heart muscle cells and replicates inside them, directly killing tissue in a process called myonecrosis. Second, the immune system responds by flooding the area with inflammatory cells and signaling molecules called cytokines, which cause further collateral damage. Third, this inflammation can trigger premature cell death (apoptosis) in heart cells that weren’t directly infected. The result is a combination of tissue destruction and swelling that can physically interrupt the electrical pathway running through the left bundle branch.
A case published in the European Heart Journal provided direct visual evidence of this process. Tissue samples from a patient with acute lymphocytic myocarditis showed T cells (immune cells) infiltrating not just the general heart muscle, but specific conduction structures: the AV node, the left anterior fascicle, and the right bundle branch. This confirms that inflammatory cells don’t just damage heart muscle broadly. They can target the exact wiring that, when disrupted, produces a bundle branch block on an ECG.
Which Viruses Are Most Often Involved
Coxsackie B viruses are among the most well-known causes of viral myocarditis and the conduction problems that follow. Antibodies against Coxsackie B accumulate over a lifetime, which is one reason viral myocarditis becomes somewhat less common after age 30. Other viruses frequently linked to myocarditis include adenoviruses, parvovirus B19, influenza, and HIV.
SARS-CoV-2 brought renewed attention to this issue. A study using the 2020 National Inpatient Sample database identified 17,365 new bundle branch block diagnoses among roughly 1.06 million COVID-19 hospitalizations. That 1.6% rate is notable because it reflects new-onset cases only, meaning these patients did not have a pre-existing conduction abnormality before their COVID-19 admission. An additional 0.4% developed high-degree AV block, another serious conduction disturbance.
What It Feels Like
A viral infection that progresses to affect the heart’s conduction system often starts with what seems like a routine illness: fever, fatigue, body aches, or respiratory symptoms. Days to weeks later, cardiac symptoms can emerge. Some people notice palpitations, a fluttering or racing sensation in the chest. Others experience shortness of breath, dizziness, or fainting (syncope), especially during exertion. In some cases, there are no obvious symptoms at all, and the LBBB is discovered incidentally on an ECG done for another reason.
The severity depends on how much heart tissue is involved. Mild myocarditis may produce a transient conduction delay that resolves as inflammation subsides. More extensive damage, particularly when it leads to scarring (fibrosis), can permanently alter the heart’s electrical pathways and reduce pumping efficiency. In pediatric patients, the presence of LBBB along with syncope or severe heart failure symptoms at presentation is considered a predictor of worse outcomes.
How Doctors Identify a Viral Cause
LBBB itself shows up on a standard 12-lead ECG as a widened QRS complex with a characteristic pattern. The challenge is figuring out why the block developed. When a previously healthy person, especially someone younger, develops a new LBBB during or shortly after a viral illness, myocarditis moves to the top of the list.
Cardiac MRI is the most useful non-invasive tool for confirming myocarditis. It can reveal areas of active inflammation and distinguish them from older scar tissue. Blood tests for markers of heart muscle injury (troponin) and inflammation (C-reactive protein) provide supporting evidence. In rare cases, a heart biopsy offers definitive proof by showing immune cells infiltrating heart tissue, though this is not routinely performed due to its invasive nature.
The distinction matters because LBBB in an older adult is more commonly caused by long-standing high blood pressure, coronary artery disease, or age-related degeneration of the conduction system. A viral cause is more likely when the onset is sudden, the patient is younger, and there’s a clear preceding illness.
Can the Block Reverse?
In some cases, yes. When LBBB results from acute inflammation and swelling rather than permanent scarring, the conduction delay can resolve as the infection clears and inflammation subsides. This is more likely when the block appears early in the illness and treatment begins promptly.
However, if the virus triggers enough tissue destruction or if chronic inflammation leads to fibrosis, the LBBB may become permanent. Data from conduction disturbances in other cardiac contexts shows that LBBB persists in roughly two out of three patients at one month, and its long-term course is difficult to predict. Some blocks that appear to resolve can recur months later.
Chronic LBBB is more than just an ECG finding. Because the left ventricle’s two sides no longer contract in sync, the heart pumps less efficiently over time. This can gradually lead to dilated cardiomyopathy, a condition where the heart chamber enlarges and weakens. For patients who develop heart failure symptoms alongside a persistent LBBB, cardiac resynchronization therapy (a specialized pacemaker that re-coordinates the ventricle’s contractions) is an established treatment option, though it’s typically considered after the acute phase of illness has resolved and the block has proven to be permanent.
Why Timing Matters
The window between a viral illness and the appearance of cardiac symptoms is important to pay attention to. Myocarditis can develop during the acute infection or emerge one to three weeks afterward, when the immune response is at its most aggressive. Chest pain, new exercise intolerance, unexplained palpitations, or fainting spells in the days to weeks following a viral illness are signals that the heart may be involved. Early identification gives the best chance of managing inflammation before it causes irreversible damage to the conduction system.